Litcius/Paper detail

380MO SKB264 (MK-2870) in previously treated hormone receptor-positive (HR+)/ HER2-negative metastatic breast cancer (mBC): Results from a phase I/II, single-arm, basket trial

Quchang Ouyang, Yongmei Yin, L. Song, Min Yan, Xiaohong Wu, Zhongsheng Tong, Ying Liu, Xuming Wang, Xiaoyan Jin, Y. Diao, Guanghua Liu, Jia Ge, Jianbin Li

2023Annals of Oncology12 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMetastatic breast cancerHormone receptorInternal medicineOncologyCancerPhases of clinical researchBreast cancerHER2 negativeChemotherapyRadiopharmaceutical Chemistry and ApplicationsCancer Treatment and PharmacologyEstrogen and related hormone effects
380MO SKB264 (MK-2870) in previously treated hormone receptor-positive (HR+)/ HER2-negative metastatic breast cancer (mBC): Results from a phase I/II, single-arm, basket trial | Litcius